MEET still has room before reaching its ATH of $8.11. It's starting to look overvalued with the near-vertical moves and the RSI beginning to move into overbought territory. There could be a short-term correction but the overall trend remains bullish.
Hi, today we are going to talk about MEET and in a Day Trade opportunity. We observe a 15m chart, some important points such as supports and resistances (and levels of strength) to the Day Trade. The details are highlighted above. Thank you for reading and leave your comments if you like. Join the Traders Heaven today, for more exclusive contents! Link...
ago This stop can double your money in a matter of days. Its a massive undervalue stock so i just buy a couple hundreds shares and ill hold. Trade at your own risk!
MEET got jumped income from acquisition. Our valuation for this stock is $8 per share
MEET has broken the uptrend on 4h with a strong impulse. I'm expecting more downside with the possible target posted on chart. Potential gain above 30%.
Shares of DSKX continues to rally from last week after they held a conference call to discuss the recently announced agreement to acquire Radiancy, Inc., a leading developer of consumer medical devices and the Neova® dermatological products. It appears investors are beginning to notice the financial value this new deal brings and the future outlook of the company,...